Compare EVH & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVH | FORM |
|---|---|---|
| Founded | 2011 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Semiconductors |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 468.7M | 4.5B |
| IPO Year | 2015 | N/A |
| Metric | EVH | FORM |
|---|---|---|
| Price | $4.07 | $55.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | $12.25 | ★ $55.75 |
| AVG Volume (30 Days) | ★ 4.2M | 654.7K |
| Earning Date | 11-06-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | ★ $2,054,052,000.00 | $759,313,000.00 |
| Revenue This Year | N/A | $3.97 |
| Revenue Next Year | $28.55 | $10.24 |
| P/E Ratio | ★ N/A | $104.87 |
| Revenue Growth | N/A | ★ 2.29 |
| 52 Week Low | $3.50 | $22.58 |
| 52 Week High | $12.98 | $61.10 |
| Indicator | EVH | FORM |
|---|---|---|
| Relative Strength Index (RSI) | 37.50 | 55.44 |
| Support Level | $3.81 | $56.88 |
| Resistance Level | $4.15 | $60.30 |
| Average True Range (ATR) | 0.22 | 1.99 |
| MACD | 0.14 | -0.10 |
| Stochastic Oscillator | 40.26 | 53.80 |
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.